Up next
Author
Tags
Share article
The post has been shared by 0 people.
Facebook 0
Twitter 0
Pinterest 0
Mail 0

Denali Therapeutics Inc.

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.

Source link

You May Also Like

Live updates: Moscow, Russia, concert hall shooting attack

Saidakrami Murodali Rachabalizoda, a suspect in the shooting attack at the Crocus…

Readers sound off on Hollywood on strike, perceptions of crime and horse advocates

Northport, L.I.: Where’s the comic relief when we need it most? This…

China aiming for less disruptive COVID policies, reports say

Chinese officials are trying to quell an outcry over the death of…

Melting glaciers could spread unseen pathogens around Earth: study

Situated on a Canadian body of land known as Ellesmere Island, Lake…